鶹 Alert / Alerte de 鶹

Updated: Fri, 07/12/2024 - 12:16

鶹 Alert. The downtown campus will remain partially closed through the evening of Monday, July 15. See the for details.

Alerte de 鶹. Le campus du centre-ville restera partiellement fermé jusqu’au lundi 15 juillet, en soirée. Complément d’information : .

Tree-lined path to the Arts Building at the 鶹 downtown campus. The 鶹 flag flies in the distance.

Under the leadership of the Vice-President, Dominique Bérubé, Research and Innovation (R+I) promotes and advances research across 鶹, through service to the research community.

Research and Innovation (R+I) is responsible for the promotion and advancement of research across 鶹 and serves the research community in a variety of ways. Specifically, R+I directs the University’s overall institutional research mandate, manages the support services framework for research initiatives, and oversees outreach to key international institutions.

Throughout the R+I portfolio, particular emphasis is placed on the cultivation, development, and support of interdisciplinary research initiatives and innovation.

Leadership Team

Learn More

the birks clock on the Roddick Gates

Learn more about 鶹 R+I's research performance, major projects, reports, and policies.

Research Units and Facilities

The Rosalind and Morris Goodman Cancer Institute Building entrance at night

Learn about 鶹's various Research Units, Facilities, Hospitals, and Chairs.

Strategic Research Plan

A smiling young woman looking through a telescope

Learn more about R+I's focus on research and innovation through our strategic research plan (SRP).

Research Advisory Council

Birks clock on the Roddick Gates

The Research Advisory Council (RAC) is the primary forum for exchange, discussion, and updates on University-wide research related dossiers between the Office of 鶹 Research and Innovation, the hospital Research Institutes, and the Faculties.

DNA to RNA (D2R) Initiative

lab technician looking into a microscope.

An inclusive Canadian approach to genomic-based RNA therapeutics, seeking funding through the Canada First Research Excellence Fund (CFREF) program.

Back to top